Annals On Call Podcast podkast

SGLT2 vs GLP1 for Cardiovascular Prevention

0:00
23:05
Do tyłu o 15 sekund
Do przodu o 15 sekund
Dr. Centor discusses the use of sodium-glucose cotransporter-2 inhibitors versus glucagon-like peptide-1 receptor agonists and the risk for cardiovascular outcomes in routine care patients with diabetes with Dr. Elisabetta Patorno.

Więcej odcinków z kanału "Annals On Call Podcast"